Rare diseases
Investigational molecules
Locations
Am Klinikum 1, Lobeda, 07747 Jena, Germany
Research activity includes chronic myeloid leukemia, with interest in treatment strategies aimed at molecular remission and disease control after targeted therapy.
Clinical work in this area also extends to combination approaches involving tyrosine kinase inhibitor discontinuation and targeted agents.
Friedrich-Schiller-Universitaet Jena runs clinical trials in conditions such as Chronic myeloid leukaemia, Cardiac failure acute, Encephalitis autoimmune, Herpes simplex, among others.
Clinical trials run by this sponsor – those enrolling participants first.
GermanyGermanyGermanyGermanyGermanyGermanyGermany
AustriaGermanyGermanyIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
